SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMGEN
AMGN 296.30-0.7%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Craig Slotoroff4/10/1996 12:38:00 PM
   of 42
 
George, I have not heard of any negative comments concerning AMGEN. In fact the only thing that I hear are good comments about AMGEN. I also own fair amount of AMGEN, and am not upset about the drop in the stock. I am watching closely, and when AMGEN seems to have bottomed out I am going to buy lots more. I have heard good estiments for AMGEN due to their neuporgen (spelling) drug. I think that the whole biotech and health care area have seen their stocks drop in recent weeks. Look at CHIR etc, all are down. I also own shares in Fidelity Health Care Sel fund which has been down sharply recently. I am not alarmed, this sector will continue to be strong.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext